Kalé Kponee-Shovein

Vice President
Kalé Kponee-Shovein

Education

Sc.D., epidemiology and environmental health, and Sc.M., biostatistics, Harvard University; M.P.H., epidemiology, Boston University; B.A., psychology and Spanish, Saint Louis University

Summary of Experience

Dr. Kponee-Shovein is an epidemiologist with expertise in causal inference methods, outcomes research, drug safety, health economics, and health care litigation. She specializes in applying innovative, rigorous, and evidence-based methods to address complex health care research questions. Dr. Kponee-Shovein has extensive experience analyzing diverse health care data sources, including insurance claims, electronic medical records, chart reviews, clinical trials, and survey data. She has provided strategic regulatory consulting on drug registration and real-world evidence generation, contributing to US Food and Drug Administration (FDA) submissions for new drug applications (NDA), supplemental new drug applications (sNDA), orphan drug designations (ODD), and FDA Type C and Type D meetings. Dr. Kponee-Shovein has led impactful research projects in resource-limited settings and coauthored numerous articles in peer-reviewed journals, including JAMA Internal Medicine and the American Journal of Epidemiology. Her work has been presented at clinical conferences as well as conferences in health economics, epidemiology, and environmental health sciences. Dr. Kponee-Shovein serves as an adjunct senior lecturer in the Department of Epidemiology at the Harvard T.H. Chan School of Public Health.

Read Kalé's profile